These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

622 related articles for article (PubMed ID: 17924870)

  • 1. Comparison of the antidiabetic effects of brain-derived neurotrophic factor and thiazolidinediones in obese diabetic mice.
    Yamanaka M; Itakura Y; Tsuchida A; Nakagawa T; Noguchi H; Taiji M
    Diabetes Obes Metab; 2007 Nov; 9(6):879-88. PubMed ID: 17924870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermittent administration of brain-derived neurotrophic factor (BDNF) ameliorates glucose metabolism and prevents pancreatic exhaustion in diabetic mice.
    Yamanaka M; Itakura Y; Ono-Kishino M; Tsuchida A; Nakagawa T; Taiji M
    J Biosci Bioeng; 2008 Apr; 105(4):395-402. PubMed ID: 18499057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective effect of brain-derived neurotrophic factor on pancreatic islets in obese diabetic mice.
    Yamanaka M; Itakura Y; Inoue T; Tsuchida A; Nakagawa T; Noguchi H; Taiji M
    Metabolism; 2006 Oct; 55(10):1286-92. PubMed ID: 16979397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain-derived neurotrophic factor enhances glucose utilization in peripheral tissues of diabetic mice.
    Yamanaka M; Tsuchida A; Nakagawa T; Nonomura T; Ono-Kishino M; Sugaru E; Noguchi H; Taiji M
    Diabetes Obes Metab; 2007 Jan; 9(1):59-64. PubMed ID: 17199719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain-derived neurotrophic factor reduces blood glucose level in obese diabetic mice but not in normal mice.
    Ono M; Ichihara J; Nonomura T; Itakura Y; Taiji M; Nakayama C; Noguchi H
    Biochem Biophys Res Commun; 1997 Sep; 238(2):633-7. PubMed ID: 9299565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain-derived neurotrophic factor (BDNF) regulates glucose and energy metabolism in diabetic mice.
    Nakagawa T; Ono-Kishino M; Sugaru E; Yamanaka M; Taiji M; Noguchi H
    Diabetes Metab Res Rev; 2002; 18(3):185-91. PubMed ID: 12112936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential modulatory effects of rosiglitazone and pioglitazone on white adipose tissue in db/db mice.
    Yang KJ; Noh JR; Kim YH; Gang GT; Hwang JH; Yang SJ; Yeom YI; Lee CH
    Life Sci; 2010 Sep; 87(13-14):405-10. PubMed ID: 20723549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of brain-derived neurotrophic factor on insulin signal transduction in the liver of diabetic mice.
    Tsuchida A; Nakagawa T; Itakura Y; Ichihara J; Ogawa W; Kasuga M; Taiji M; Noguchi H
    Diabetologia; 2001 May; 44(5):555-66. PubMed ID: 11380073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of glucose tolerance in Zucker diabetic fatty rats by long-term treatment with the dipeptidyl peptidase inhibitor P32/98: comparison with and combination with rosiglitazone.
    Wargent E; Stocker C; Augstein P; Heinke P; Meyer A; Hoffmann T; Subramanian A; Sennitt MV; Demuth HU; Arch JR; Cawthorne MA
    Diabetes Obes Metab; 2005 Mar; 7(2):170-81. PubMed ID: 15715890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muraglitazar, a novel dual (alpha/gamma) peroxisome proliferator-activated receptor activator, improves diabetes and other metabolic abnormalities and preserves beta-cell function in db/db mice.
    Harrity T; Farrelly D; Tieman A; Chu C; Kunselman L; Gu L; Ponticiello R; Cap M; Qu F; Shao C; Wang W; Zhang H; Fenderson W; Chen S; Devasthale P; Jeon Y; Seethala R; Yang WP; Ren J; Zhou M; Ryono D; Biller S; Mookhtiar KA; Wetterau J; Gregg R; Cheng PT; Hariharan N
    Diabetes; 2006 Jan; 55(1):240-8. PubMed ID: 16380499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of dipeptidylpeptidase IV inhibitor and low dose thiazolidinedione: preclinical efficacy and safety in db/db mice.
    Roy S; Khanna V; Mittra S; Dhar A; Singh S; Mahajan DC; Priyadarsiny P; Davis JA; Sattigeri J; Saini KS; Bansal VS
    Life Sci; 2007 Jun; 81(1):72-9. PubMed ID: 17532347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients.
    Miyazaki Y; DeFronzo RA
    Diabetes Obes Metab; 2008 Dec; 10(12):1204-11. PubMed ID: 18476983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-diabetic effects of ethanol extract from two variants of Artemisia princeps Pampanini in C57BL/KsJ-db/db mice.
    Jung UJ; Baek NI; Chung HG; Bang MH; Yoo JS; Jeong TS; Lee KT; Kang YJ; Lee MK; Kim HJ; Yeo JY; Choi MS
    Food Chem Toxicol; 2007 Oct; 45(10):2022-9. PubMed ID: 17574717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the novel oral antidiabetic agent HQL-975 on glucose and lipid metabolism in diabetic db/db mice.
    Ishikawa Y; Watanabe K; Takeno H; Tani T
    Arzneimittelforschung; 1998 Mar; 48(3):245-50. PubMed ID: 9553681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice.
    Nakagawa T; Tsuchida A; Itakura Y; Nonomura T; Ono M; Hirota F; Inoue T; Nakayama C; Taiji M; Noguchi H
    Diabetes; 2000 Mar; 49(3):436-44. PubMed ID: 10868966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihyperglycemic effect of a new thiazolidinedione analogue and its role in ameliorating oxidative stress in alloxan-induced diabetic rats.
    Chaudhry J; Ghosh NN; Roy K; Chandra R
    Life Sci; 2007 Feb; 80(12):1135-42. PubMed ID: 17234217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic improvement in insulin resistance with a combination of fenofibrate and rosiglitazone in obese type 2 diabetic mice.
    Choi WS; Lee JJ; Kim Y; Kim IS; Zhang WY; Myung CS
    Arch Pharm Res; 2011 Apr; 34(4):615-24. PubMed ID: 21544727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fenofibrate prevents Rosiglitazone-induced body weight gain in ob/ob mice.
    Carmona MC; Louche K; Nibbelink M; Prunet B; Bross A; Desbazeille M; Dacquet C; Renard P; Casteilla L; Pénicaud L
    Int J Obes (Lond); 2005 Jul; 29(7):864-71. PubMed ID: 15917863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin sensitizing activity of ethyl acetate fraction of Acorus calamus L. in vitro and in vivo.
    Wu HS; Zhu DF; Zhou CX; Feng CR; Lou YJ; Yang B; He QJ
    J Ethnopharmacol; 2009 Jun; 123(2):288-92. PubMed ID: 19429374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of adipocytokine mRNAs by rosiglitazone in db/db mice.
    Moore GB; Chapman H; Holder JC; Lister CA; Piercy V; Smith SA; Clapham JC
    Biochem Biophys Res Commun; 2001 Aug; 286(4):735-41. PubMed ID: 11520059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.